Cargando…
Common drugs, vitamins, nutritional supplements and COVID-19 mortality
The FDA has approved only one drug, remdesivir, for the treatment of COVID-19. The FDA has granted an emergency use authorization for the rheumatoid arthritis treatment drug, baricitinib (Olumiant), for the treatment of COVID-19 in some cases. For this reason, investigators have paid considerable at...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323622/ https://www.ncbi.nlm.nih.gov/pubmed/34337612 http://dx.doi.org/10.3892/ijfn.2021.14 |